» Articles » PMID: 31682851

Causes of Socioeconomic Disparities in Colorectal Cancer and Intervention Framework and Strategies

Overview
Specialty Gastroenterology
Date 2019 Nov 5
PMID 31682851
Citations 130
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) disproportionately affects people from low socioeconomic backgrounds and some racial minorities. Disparities in CRC incidence and outcomes might result from differences in exposure to risk factors such as unhealthy diet and sedentary lifestyle; limited access to risk-reducing behaviors such as chemoprevention, screening, and follow-up of abnormal test results; or lack of access to high-quality treatment resources. These factors operate at the individual, provider, health system, community, and policy levels to perpetuate CRC disparities. However, CRC disparities can be eliminated. Addressing the complex factors that contribute to development and progression of CRC with multicomponent, adaptive interventions, at multiple levels of the care continuum, can reduce gaps in mortality. These might be addressed with a combination of health care and community-based interventions and policy changes that promote healthy behaviors and ensure access to high-quality and effective measures for CRC prevention, diagnosis, and treatment. Improving resources and coordinating efforts in communities where people of low socioeconomic status live and work would increase access to evidence-based interventions. Research is also needed to understand the role and potential mechanisms by which factors in diet, intestinal microbiome, and/or inflammation contribute to differences in colorectal carcinogenesis. Studies of large cohorts with diverse populations are needed to identify epidemiologic and molecular factors that contribute to CRC development in different populations.

Citing Articles

Differential Colorectal Cancer Mortality Across Racial and Ethnic Groups: Impact of Socioeconomic Status, Clinicopathology, and Treatment-Related Factors.

Fwelo P, Adekunle T, Adekunle T, Garza E, Huang E, Lawrence W Cancer Med. 2025; 14(5):e70612.

PMID: 40040375 PMC: 11880620. DOI: 10.1002/cam4.70612.


Re-screening adherence to multi-target stool DNA test for colorectal cancer: real-world study in a large national population.

Greene M, Pew T, Dore M, Ebner D, Ozbay A, Johnson W Int J Colorectal Dis. 2025; 40(1):48.

PMID: 39992481 PMC: 11850584. DOI: 10.1007/s00384-025-04837-6.


Fecal Immunochemical Testing for Colorectal Cancer Prevention in Two Public Hospitals.

Gong C, Medina Rojas M, Rubianes Guerrero M, Kladas M, Mousakhanian A, Sudan A J Gastrointest Cancer. 2025; 56(1):69.

PMID: 39985680 PMC: 11846761. DOI: 10.1007/s12029-025-01187-y.


Health Disparities: The Emerging Trends and Pressing Challenges.

Dopelt K Eur J Investig Health Psychol Educ. 2025; 15(1).

PMID: 39852190 PMC: 11765355. DOI: 10.3390/ejihpe15010007.


A socioecological taxonomy of determinants to colorectal cancer screening in black men: Insights from a mixed-methods systematic review.

Zaire P, Miller E, Ewing A, Hefner J, Wright K, Smith L Prev Med Rep. 2025; 49:102954.

PMID: 39834382 PMC: 11743892. DOI: 10.1016/j.pmedr.2024.102954.


References
1.
Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View

2.
Meester R, Doubeni C, Lansdorp-Vogelaar I, Goede S, Levin T, Quinn V . Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol. 2015; 25(3):208-213.e1. PMC: 4554530. DOI: 10.1016/j.annepidem.2014.11.011. View

3.
Carethers J, Stoffel E . Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer. World J Gastroenterol. 2015; 21(31):9253-61. PMC: 4541378. DOI: 10.3748/wjg.v21.i31.9253. View

4.
Naylor K, Ward J, Polite B . Interventions to improve care related to colorectal cancer among racial and ethnic minorities: a systematic review. J Gen Intern Med. 2012; 27(8):1033-46. PMC: 3403155. DOI: 10.1007/s11606-012-2044-2. View

5.
Jensen C, Doubeni C, Quinn V, Levin T, Zauber A, Schottinger J . Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. Clin Gastroenterol Hepatol. 2014; 13(4):739-46. PMC: 4369190. DOI: 10.1016/j.cgh.2014.10.020. View